Equities Analysts Offer Predictions for YMAB FY2025 Earnings
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) – Cantor Fitzgerald lowered their FY2025 earnings estimates for Y-mAbs Therapeutics in a research note issued on Wednesday, March 5th. Cantor Fitzgerald analyst L. Watsek now anticipates that the company will post earnings per share of ($0.92) for the year, down from their prior forecast of ($0.67). The […]
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) – Cantor Fitzgerald lowered their FY2025 earnings estimates for Y-mAbs Therapeutics in a research note issued on Wednesday, March 5th. Cantor Fitzgerald analyst L. Watsek now anticipates that the company will post earnings per share of ($0.92) for the year, down from their prior forecast of ($0.67). The […]
